KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 87 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $6,420,000 | +36.6% | 500 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $4,700,000 | -3.4% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $4,865,000 | +45.0% | 500 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $3,355,000 | -24.8% | 500 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $4,460,000 | +68.3% | 500 | +150.0% | 0.00% | +50.0% |
| Q4 2015 | $2,650,000 | -2.6% | 200 | +100.0% | 0.00% | 0.0% |
| Q2 2015 | $2,721,000 | -11.1% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $3,061,000 | -18.2% | 100 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $3,743,000 | +22.3% | 100 | 0.0% | 0.00% | +50.0% |
| Q1 2014 | $3,061,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |